{"id":"https://genegraph.clinicalgenome.org/r/53040719-d966-4d0b-873c-073a8e334242v1.2","type":"EvidenceStrengthAssertion","dc:description":["Variants in *GABRB2* were first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2011 (Kumari et al., PMID 21420396). Individuals with variants in *GABRB2* can present with features such as developmental and epileptic encephalopathy, early-onset epilepsy, various types of seizures, fever sensitivity, developmental delay, intellectual disability, and movement disorders (PMIDs: 27789573, 32686847, 33325057). \n\nSixteen missense variants that have been reported in 20 probands in 5 publications (PMIDs: 25124326, 27789573, 29100083, 32686847, 33325057) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Most variants occur *de novo* but may also be inherited from an affected parent. Functional analysis of four missense variants demonstrated that they resulted in loss of function (PMID: 33325057).  Pathogenic variants are localized in regions intolerant to functional variation,  and cluster in the extracellular N-terminus and transmembrane domains 1–3. No truncating variants or deletions have been identified to date in affected individuals (PMID: 33325057). \n\nIn summary, there is definitive evidence supporting the relationship between *GABRB2* and autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on January 16, 2024 (SOP 10).\n\n\n\n\n\n\n","Variants in *GABRB2* were first reported in relation to autosomal dominant  developmental and epileptic encephalopathy in 2011 (Kumari R et al.;PMID 21420396). Individuals with variants in *GABRB2* can present with features such as developmental and epileptic encephalopathies, early-onset epilepsy, developmental delay, seizures, fever sensitivity, and movement disorder (PMIDs: 27789573, 32686847, 33325057). \n\nSixteen variants (missense) that have been reported in 20 probands in 5 publications (PMIDs: 25124326,29100083, 27789573, 32686847, 33325057) are included in this curation. More evidence is available in the literature, but the maximum genetic evidence (12 points) has been reached. Per El Achkar et al., “experimental evidence supports loss of GABAergic inhibition as the mechanism underlying GABRB2-associated neurodevelopmental disorders” (PMID :33325057).\n\nIn summary, there is definitive evidence to support the relationship between *GABRB2* and developmental and epileptic encephalopathy. This has been consistently demonstrated in clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism GCEP on January 16, 2024 (SOP 10).\n\n\n\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/53040719-d966-4d0b-873c-073a8e334242","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5589d3aa-cb45-4b9f-bf8e-2000d1a780bd","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5589d3aa-cb45-4b9f-bf8e-2000d1a780bd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-01-24T17:12:01.067Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/5589d3aa-cb45-4b9f-bf8e-2000d1a780bd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2024-01-16T17:00:00.000Z","2024-01-16T05:00:00.000Z"],"role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5589d3aa-cb45-4b9f-bf8e-2000d1a780bd_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5589d3aa-cb45-4b9f-bf8e-2000d1a780bd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b432cc2-0ff3-4d87-ace6-f7d5d051a455","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b432cc2-0ff3-4d87-ace6-f7d5d051a455_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/d15f4a2e-1334-4d46-817f-694361435c27","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.830T>C (p.Leu277Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362171472"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f4e357cb-9443-446a-9117-3cc1c72522b9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4e357cb-9443-446a-9117-3cc1c72522b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0b8bb6c-80f6-4f6b-ae30-a9c35e2cf058","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.735T>A (p.Phe245Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362171683"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a84b33fe-612b-44a7-891a-c8b8c4612585","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a84b33fe-612b-44a7-891a-c8b8c4612585_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a2c78f7-509b-4295-971d-c4ac59878ddb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.755C>T (p.Pro252Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362171635"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a84b33fe-612b-44a7-891a-c8b8c4612585_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of 4 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents (LOF)\n\nExperimental evidence supports loss of GABA-ergic inhibition as the mechanism underlying GABRB2-associated neurodevelopmental disorders.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ba313a81-b33e-4771-a9f6-51ebaed59197","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba313a81-b33e-4771-a9f6-51ebaed59197_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/a01362fe-b251-47d2-a94c-ba4b72e102c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.236T>C (p.Met79Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA233353"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/313f73a2-7c95-47b2-871b-a8ca07a089b4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/313f73a2-7c95-47b2-871b-a8ca07a089b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/e78f013a-3e3e-4f65-9153-278a2d45eee9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.910G>A (p.Ala304Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362175362"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a98205da-fd92-4d86-9684-7789fd724b3b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a98205da-fd92-4d86-9684-7789fd724b3b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/8fa848b5-4e56-4ee8-b1f1-1877ac249b2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.911C>T (p.Ala304Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362175357"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5c8b73d4-b33e-4d4b-9aca-cc2f69376338","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c8b73d4-b33e-4d4b-9aca-cc2f69376338_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32686847","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb464f1f-3524-4670-afe7-ade58f072467","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.754C>A (p.Pro252Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362171639"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cccbcd59-7093-479f-b4c7-6ce2c92a512a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cccbcd59-7093-479f-b4c7-6ce2c92a512a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a53bfa3-63e2-4aa9-8d65-8c6bc99a70d0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.730T>C (p.Tyr244His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362171697"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/abb5a018-444c-49fd-8c78-a0e678f9443a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abb5a018-444c-49fd-8c78-a0e678f9443a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb1314e8-3735-413a-9f40-3ad4d8cca001","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.845T>C (p.Val282Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10588396"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/abb5a018-444c-49fd-8c78-a0e678f9443a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of 4 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents (LOF)\n\nExperimental evidence supports loss of GABA-ergic inhibition as the mechanism underlying GABRB2-associated neurodevelopmental disorders.\n\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/de0a9978-22f6-4660-a983-b837f1d75dee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de0a9978-22f6-4660-a983-b837f1d75dee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/3867d648-e991-438d-96cb-f3895bc07298","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.896T>G (p.Ile299Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16618149"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/073d3477-46a2-4132-9197-8e32df631add","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/073d3477-46a2-4132-9197-8e32df631add_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27789573","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b7e37a9-9933-44bd-905e-8877f1de1087","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.859A>C (p.Thr287Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362175468"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/073d3477-46a2-4132-9197-8e32df631add_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":" In vitro functional expression studies in HEK293 cells showed that the mutation resulted in decreased total GABRB2 expression and caused a 66% decrease in cell surface expression. GABA receptors containing the mutant beta-2 subunit were retained within the cell. Peak amplitudes of currents from GABA receptors containing the mutant subunit were decreased by 96.4%, indicating significant Cl- channel dysfunction. Ishii et al. (2017) postulated that the mutation caused a dominant-negative effect when expressed with other receptor subunits","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/da7782d9-18cc-4f8c-9886-62765b866a77","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da7782d9-18cc-4f8c-9886-62765b866a77_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7dda1c3-9457-4ad9-a144-339c889adb57","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.904G>A (p.Val302Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362175375"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/34d555a3-2068-428c-9eea-c149b262789e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34d555a3-2068-428c-9eea-c149b262789e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e94b721-34d6-488c-b21a-d6a5184927bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.908A>G (p.Lys303Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362175365"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4af80aec-a927-45d8-9deb-29f76a7cec58","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4af80aec-a927-45d8-9deb-29f76a7cec58_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/cc57faa3-33c0-4f0e-a826-3d80790b3f06","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.754C>G (p.Pro252Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357915"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5f30cfa9-bbf4-49a2-957e-3e4ac16a0803","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f30cfa9-bbf4-49a2-957e-3e4ac16a0803_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/e1353d31-9b23-4d67-af8b-0977b953e2d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.373G>A (p.Asp125Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362173878"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/31a52b19-2a96-4a48-a34a-2f574cc0562f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31a52b19-2a96-4a48-a34a-2f574cc0562f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33325057","allele":{"id":"https://genegraph.clinicalgenome.org/r/019eba9a-91cc-4ced-b28f-8da595380e32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371727.1(GABRB2):c.737T>C (p.Ile246Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16618152"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/31a52b19-2a96-4a48-a34a-2f574cc0562f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of 4 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents (LOF)\n\nExperimental evidence supports loss of GABA-ergic inhibition as the mechanism underlying GABRB2-associated neurodevelopmental disorders.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/deca5a71-ef9f-49b2-a312-406463cd0130","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/deca5a71-ef9f-49b2-a312-406463cd0130_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e94b721-34d6-488c-b21a-d6a5184927bd"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/be20da41-7aed-40b9-8a5a-347998c9a5e1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be20da41-7aed-40b9-8a5a-347998c9a5e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/d15f4a2e-1334-4d46-817f-694361435c27"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/78459067-2b40-4268-a6bb-72c3ac42bee4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78459067-2b40-4268-a6bb-72c3ac42bee4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25124326","allele":{"id":"https://genegraph.clinicalgenome.org/r/a01362fe-b251-47d2-a94c-ba4b72e102c6"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5c3299f2-f34e-43c5-aa7e-04922d9f56a8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c3299f2-f34e-43c5-aa7e-04922d9f56a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29100083","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a53bfa3-63e2-4aa9-8d65-8c6bc99a70d0"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9853,"specifiedBy":"GeneValidityCriteria10","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/kCFegVhxPd0","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:4082","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5589d3aa-cb45-4b9f-bf8e-2000d1a780bd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}